Last month I posted a scheme for the synthesis of a late-stage intermediate towards AZD9833, a compound identified by AstraZeneca as a selective estrogen receptor degrader (SERD) and antagonist that is currently in phase 2b clinical trials for the treatment of ER+ breast cancer. I asked if you could identify reagents or intermediates A-C. Below are the answers! You can read more here in the full reference: J. Scott et al, J. Med. Chem. 2020, 63, 14530–14559
Identify the reagents 4: answers
Recent articles from the lab
Living in a “Material World”
Written by Jonathan Moseley, April 17th 2024 No relation to the Madonna song, but rather the title of a book by Ed Conway, an economist and journalist, regarding the Material World in which we live. And if like me, you have a general interest in chemistry, as well as some interest in economics and history…
Put and Take Shakes It Up
In this post I’m highlighting a couple of papers that are essentially two sides of the same coin. As a process chemist, I’ll be the first to admit that the chemistry I’m about to describe is not going to end up in your manufacturing route any time soon, but as a former card-carrying medicinal chemist…
Some Elements are More Equal Than Others
In George Orwell’s classic 1945 novella ‘Animal Farm’ the revolutionary livestock develop the slogan “Four legs good, two legs bad” to summarize their views on the farmer and other humans. As the novella progresses, we see that things cannot be simplified so readily, and so I was encouraged by the recent excellent article by Brianna…